Accéder au contenu
Merck

Structural studies of human insulin cocrystallized with phenol or resorcinol via powder diffraction.

Acta crystallographica. Section D, Biological crystallography (2012-11-16)
Fotini Karavassili, Anastasia E Giannopoulou, Eleni Kotsiliti, Lisa Knight, Mathias Norrman, Gerd Schluckebier, Lene Drube, Andrew N Fitch, Jonathan P Wright, Irene Margiolaki
RÉSUMÉ

The effects of the ligands phenol and resorcinol on the crystallization of human insulin have been investigated as a function of pH. Powder diffraction data were used to characterize several distinct polymorphic forms. A previously unknown polymorph with monoclinic symmetry (P2(1)) was identified for both types of ligand with similar characteristics [the unit-cell parameters for the insulin-resorcinol complex were a = 114.0228 (8), b = 335.43 (3), c = 49.211 (6) Å, β = 101.531 (8)°].

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Resorcinol, ACS reagent, ≥99.0%
Sigma-Aldrich
Resorcinol, ReagentPlus®, 99%
Sigma-Aldrich
Resorcinol, ≥98%, FG
Sigma-Aldrich
Resorcinol, meets analytical specification of Ph. Eur., BP, 98.5-100.5% (calc. to the dried substance)
Supelco
Resorcinol, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Resorcinol, BioXtra, ≥99%